Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Laser Vision Centers, Inc. (NASDAQ: LVCI) -- Ignore unavailable to you. Want to Upgrade?

To: Xavier who wrote (182)	11/30/1998 6:28:00 PM
From: Jim Mac	Read Replies (1) \| Respond to of 413

Xavier, you're still on board? Great! Keep in mind the RSR acquisition in October quarter was only 2 months, and should grow nicely, since demand for microkeratomes (BLECH!!) is already outstripping supply. Myopia procedures next year may grow by another 150,000 nationwide, with maybe 50,000 hyperopia. Hopefully more. This industry is still in early growth stage, and relatively undiscovered by most people. Next year is when the strong year-to-year EPS comparisons will kick in. Like maybe 50-100%+ growth rates all year.